Insulet Corporation (BIT:1PODD)

Italy · Delayed Price · Currency is EUR

269.30

+8.50 (3.26%)

At close: Dec 3, 2025

18.74% (1Y)

Market Cap	18.41B
Revenue (ttm)	2.15B
Net Income (ttm)	209.84M
Shares Out	n/a
EPS (ttm)	2.94
PE Ratio	87.75
Forward PE	52.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2
Open	n/a
Previous Close	260.80
Day's Range	n/a
52-Week Range	218.40 - 306.90
Beta	n/a
RSI	41.51
Earnings Date	Feb 26, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 2000

Employees 3,900

Stock Exchange Borsa Italiana

Ticker Symbol 1PODD

Full Company Profile

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD Financial Statements

News

There is no news available yet.